Lead Product(s): COVID 19 vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Vaccine
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership July 01, 2020
Intravacc will have access to iBoost technology for the development of new cancer immunotherapy vaccines in mutually agreed upon countries.